Clinical Management of Challenges in Allogeneic Stem Cell Transplant
Series: Advances in Experimental Medicine and Biology; 1475;
- Publisher's listprice EUR 139.09
-
57 687 Ft (54 940 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 11 537 Ft off)
- Discounted price 46 150 Ft (43 952 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
57 687 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer Nature Switzerland
- Date of Publication 10 June 2025
- Number of Volumes 1 pieces, Book
- ISBN 9783031849879
- Binding Hardback
- No. of pages228 pages
- Size 254x178 mm
- Language English
- Illustrations VIII, 228 p. 6 illus., 5 illus. in color. Illustrations, black & white 669
Categories
Long description:
The purpose of the book is to focus attention and offer suggestions on controversial and challenging topics in allogeneic stem cell transplant. Over 40,000 allogeneic hematopoietic cell transplants (HCT) are done worldwide each year. Despite advances in allogeneic transplant, the cure rate is only 50-70%, depending on disease and patient factors. The book focuses on key topics such as patient selection, donor selection, conditioning regimens, graft vs. host disease prophylaxis regimens, maintenance strategies, and other topics that affect patient outcomes. The authors also discuss access to transplant care. Through dissemination of these topics, we hope to educate health care professionals caring for these patients, and improve patient outcomes. This is an essential resource for transplant physicians, hematologists/oncologists, and advance practice providers. Several of the topics are controversial issues that are discussed “round the table” frequently by transplant teams.
MoreTable of Contents:
Access to Transplant Care and Social Determinants of Health.- Allogeneic Transplantation for Older Adults.- Conditioning Regimen Options.- Graft source choice.- Optimal GVHD Prophylaxis.- Modern era challenges in the clinical management of graft versus host disease.- Acute Myeloid Leukemia Use of Measurable Residual Disease to Improve Outcomes.- Clinical Management of Challenges in Allogeneic Stem Cell Transplant.- Myelofibrosis Timing of Transplantation and Management of Splenomegaly.- Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.- Pharmacological Maintenance Therapies after Allogeneic Hematopoietic Cell Transplantation.- Challenges and opportunities in the care of hematopoietic cell transplant survivors in the modern era.
More
